专题报道:芳香化酶抑制剂的临床应用 |
|
|
|
|
来曲唑对21-羟化酶缺乏型先天性肾上腺皮质增生症患儿生长发育的影响 |
王倩1( ),张书乐2,马雪2,李桂梅1,*( ),王增敏1,王凤雪1 |
1. 山东第一医科大学附属省立医院小儿内分泌综合科, 山东 济南 250014 2. 山东大学附属省立医院小儿内分泌综合科, 山东 济南 250014 |
|
Efficacy of letrozole in treatment of children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency |
WANG Qian1( ),ZHANG Shule2,MA Xue2,LI Guimei1,*( ),WANG Zengmin1,WANG Fengxue1 |
1. Department of Pediatric Endocrine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250014, China 2. Department of Pediatric Endocrine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250014, China |
引用本文:
王倩,张书乐,马雪,李桂梅,王增敏,王凤雪. 来曲唑对21-羟化酶缺乏型先天性肾上腺皮质增生症患儿生长发育的影响[J]. 浙江大学学报(医学版), 2020, 49(3): 302-307.
WANG Qian,ZHANG Shule,MA Xue,LI Guimei,WANG Zengmin,WANG Fengxue. Efficacy of letrozole in treatment of children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Zhejiang Univ (Med Sci), 2020, 49(3): 302-307.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2020.04.04
或
http://www.zjujournals.com/med/CN/Y2020/V49/I3/302
|
1 |
EL-MAOUCHE D , ARLT W , MERKE D P . Congenital adrenal hyperplasia[J]. Lancet, 2017, 390 (10108): 2194- 2210
doi: 10.1016/S0140-6736(17)31431-9
|
2 |
MERKE D P , KEIL M F , JONES J V et al. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia[J]. J Clin Endocrinol Metab, 2000, 85 (3): 1114- 1120
doi: 10.1210/jcem.85.3.6462
|
3 |
PIGNATELLI D , PEREIRA S S , PASQUALI R . Androgens in congenital adrenal hyperplasia[J]. Front Horm Res, 2019, 53 65- 76
doi: 10.1159/000494903
|
4 |
MUTHUSAMY K , ELAMIN M B , SMUSHKIN G et al. Clinical review:Adult height in patients with congenital adrenal hyperplasia:a systematic review and metaanalysis[J]. J Clin Endocrinol Metab, 2010, 95 (9): 4161- 4172
doi: 10.1210/jc.2009-2616
|
5 |
JUAN L , HUAMEI M , ZHE S et al. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency:a single-center study from China[J]. J Pediatr Endocrinol Metab, 2016, 29 (7): 841- 848
doi: 10.1515/jpem-2015-0406
|
6 |
MAHESHWARI A , KHADILKAR V , GANGODKAR P et al. Long-term growth in congenital adrenal hyperplasia[J]. Indian J Pediatr, 2019, 86 (2): 154- 158
doi: 10.1007/s12098-018-2753-6
|
7 |
GVVEN A , NURCAN CEBECI A , HANCILI S . Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty[J]. Hormones (Athens), 2015, 14 (2): 265- 271
doi: 10.14310/horm.2002.1555
|
8 |
中华医学会儿科学分会内分泌遗传代谢病学组 . 先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识[J]. 中华儿科杂志, 2016, 56 (8): 569- 575 Group of Pediatric Endocrine and Genetic Metabolic, Chinese Pediatric Society, Chinese Medical Association . Diagnosis and treatment of congenital adrenal hyperplasia with 21-hydroxylase deficiency[J]. Chinese Journal of Pediatrics, 2016, 56 (8): 569- 575
doi: 10.3760/cma.j.issn.0578-1310.2016.08.003
|
9 |
李辉, 季成叶, 宗心南 et al. 中国0~18岁儿童、青少年身高、体重的标准化生长曲线[J]. 中华儿科杂志, 2009, 47 (7): 487- 490 LI Hui , JI Chengye , ZONG Xinnan et al. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years[J]. Chinese Journal of Pediatrics, 2009, 47 (7): 487- 490
doi: 10.3760/cma.j.issn.0578-1310.2009.07.003
|
10 |
THODBERG H H, JUUL A, LOMHOLT J, et al. Adult height prediction models[M]//RODRIGUES D, WOLFORD L. Handbook of Growth and Growth Monitoring in Health and Disease. Springer Science + Business Media, 2012: 27-57.
|
11 |
潘嘉严, 张先来, 徐东 . TW3成年身高预测改良法在中国儿童中的应用研究[J]. 现代医学, 2018, 46 (7): 773- 780 PAN Jiayan , ZHANG Xianlai , XU Dong . Application of improved TW3 method in predicting adult height in Chinese children[J]. Modern Medical Journal, 2018, 46 (7): 773- 780
doi: 10.3969/j.issn.1671-7562.2018.07.011
|
12 |
SHULMAN D I, FRANCIS G L, PALMERT M R, et al. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development[J/OL]. Pediatrics, 2008, 121(4): e975-e983. DOI: 10.1542/peds.2007-2081.
|
13 |
MAURAS N , ROSS J L , GAGLIARDI P et al. Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature[J]. J Clin Endocrinol Metab, 2016, 101 (12): 4984- 4993
doi: 10.1210/jc.2016-2891
|
14 |
ESTRADA A , BOYCE A M , BRILLANTE B A et al. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome[J]. Eur J Endocrinol, 2016, 175 (5): 477- 483
doi: 10.1530/EJE-16-0526
|
15 |
LANE L C , FLOWERS J , JOHNSTONE H et al. Adult height in patients with familial male-limited precocious puberty and the role of an aromatase inhibitor in patient management[J]. J Pediatr Endocrinol Metab, 2018, 31 (5): 551- 560
doi: 10.1515/jpem-2017-0363
|
16 |
HERO M , NORJAVAARA E , DUNKEL L . Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature:a randomized controlled trial[J]. J Clin Endocrinol Metab, 2005, 90 (12): 6396- 6402
doi: 10.1210/jc.2005-1392
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|